The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1671
March 6, 2023
View Complete Issue         Table of Contents 2019 
Issue 1671
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Antiviral Drugs for COVID-19 in Vaccinated Outpatients
March 6, 2023 (Issue: 1671)
Three products are currently available in the US for treatment of high-risk,1 nonhospitalized adults with mild to moderate COVID-19: oral ritonavir-boosted nirmatrelvir (Paxlovid), IV remdesivir (Veklury), and oral molnupiravir (Lagevrio)....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1671
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.